Maze Therapeutics, Inc. (MAZE)
42.60
+1.11
(+2.68%)
USD |
NASDAQ |
Dec 04, 16:00
42.58
-0.02
(-0.06%)
After-Hours: 20:00
Maze Therapeutics Total Assets (Quarterly): 422.06M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CDT Equity, Inc. | 8.552M |
| LENZ Therapeutics, Inc. | 210.70M |
| Liminatus Pharma, Inc. | 1.342M |
| Oruka Therapeutics, Inc. | 509.25M |
| MapLight Therapeutics, Inc. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 42.62M |
| Shareholders Equity (Quarterly) | 379.44M |
| Debt to Equity Ratio | 0.0637 |
| Current Ratio | 17.70 |
| Net Debt Paydown Yield | -0.39% |